Progress in laboratory assessment of multiple myeloma
10.3760/cma.j.cn114452-20191129-00699
- VernacularTitle:多发性骨髓瘤的实验室检测进展
- Author:
Guiping LIU
1
;
Jie LI
;
Ling JI
Author Information
1. 广东医科大学研究生院，湛江 524023；北京大学深圳医院检验科，深圳 518036
- From:
Chinese Journal of Laboratory Medicine
2020;43(4):495-501
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myeloma is a clonal plasma cell malignant disorder.The treatment efficiency and overall survival rate of MM patients were significantly improved by the application of targeted therapy, chimeric antigen receptor (CAR) T-Cell Therapy and autologous stem cell transplant (ASCT). Meanwhile, the demands for newly diagnosis technologies and laboratory examination methods are required. Especially for those methods with higher sensitivity and specificity that could fit for the precise evaluation of treatment and prognosis. This review outlines the guidelines and clinical testing approaches for the diagnosis and prognosis evaluations of multiple myeloma.
